Prognostic factors for outcomes. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Lymph Nodes Neoplastic Cells, Circulating Cell Line, Tumor Bile Ducts, Intrahepatic Bone Marrow Lymphocytes, Tumor-Infiltrating

Diseases84

Lymphatic Metastasis Neoplasm Recurrence, Local Breast Neoplasms Disease Progression Neoplasm Invasiveness Lung Neoplasms Adenocarcinoma Recurrence Neoplasm Metastasis Carcinoma, Squamous Cell Stomach Neoplasms Liver Neoplasms Carcinoma Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Brain Neoplasms Melanoma Ovarian Neoplasms Kidney Neoplasms Acute Disease Hodgkin Disease Sarcoma Esophageal Neoplasms Skin Neoplasms Carcinoma, Renal Cell Carcinoma, Ductal, Breast Bone Neoplasms Carcinoma, Hepatocellular Neoplasm, Residual Lymphoma, Large B-Cell, Diffuse Leukemia, Myeloid, Acute Lymphoma, Non-Hodgkin Multiple Myeloma Bile Duct Neoplasms Cholangiocarcinoma Postoperative Complications Adenocarcinoma, Mucinous Precursor Cell Lymphoblastic Leukemia-Lymphoma Prostatic Neoplasms Rectal Neoplasms Soft Tissue Neoplasms Leukemia, Lymphocytic, Chronic, B-Cell Supratentorial Neoplasms Pancreatic Neoplasms Chromosome Aberrations Neoplastic Cells, Circulating Nasopharyngeal Neoplasms Myocardial Infarction Neoplasms, Glandular and Epithelial Cystadenocarcinoma, Serous Urinary Bladder Neoplasms Endometrial Neoplasms Head and Neck Neoplasms Leukemia, Myeloid Gastrointestinal Neoplasms Pleural Neoplasms Osteosarcoma Astrocytoma Stroke Myelodysplastic Syndromes Carcinoma, Transitional Cell Uterine Cervical Neoplasms Neovascularization, Pathologic Carcinoma, Papillary Heart Failure Laryngeal Neoplasms Chronic Disease Oligodendroglioma Glioma Neuroblastoma Lymphoma, Follicular Neoplasms Lymphoma, B-Cell Mesothelioma Thyroid Neoplasms Glioblastoma Mouth Neoplasms Carcinoma, Small Cell Retroperitoneal Neoplasms Peritoneal Neoplasms Adenocarcinoma, Clear Cell Carcinoma, Lobular Carcinoma, Endometrioid Cerebellar Neoplasms

Chemicals and Drugs41

Tumor Markers, Biological Ki-67 Antigen Vincristine Cyclophosphamide Receptors, Estrogen Prednisone Biological Markers Receptor, erbB-2 Doxorubicin Antineoplastic Agents Receptors, Progesterone Neoplasm Proteins Tumor Suppressor Protein p53 L-Lactate Dehydrogenase Cisplatin DNA, Neoplasm Fluorouracil alpha-Fetoproteins Etoposide Methotrexate RNA, Messenger Bleomycin Antigens, Neoplasm Carcinoembryonic Antigen Cytarabine Procarbazine Prostate-Specific Antigen CA-19-9 Antigen Melphalan Mechlorethamine Vinblastine Antineoplastic Agents, Hormonal Fluorodeoxyglucose F18 Antibodies, Monoclonal, Murine-Derived Lomustine Vindesine Antibodies, Monoclonal Radiopharmaceuticals NM23 Nucleoside Diphosphate Kinases Keratin-19 Vascular Endothelial Growth Factor A

Analytical, Diagnostic and Therapeutic Techniques and Equipment100

Prognosis Treatment Outcome Survival Analysis Survival Rate Retrospective Studies Neoplasm Staging Multivariate Analysis Follow-Up Studies Disease-Free Survival Kaplan-Meier Estimate Proportional Hazards Models Predictive Value of Tests Prospective Studies Immunohistochemistry Risk Factors Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Cohort Studies Pregnancy Outcome Risk Assessment Chemotherapy, Adjuvant Tissue Array Analysis Severity of Illness Index Neoplasm Grading Remission Induction Analysis of Variance Chi-Square Distribution Mitotic Index Karnofsky Performance Status Radiotherapy, Adjuvant Immunoenzyme Techniques Randomized Controlled Trials as Topic Logistic Models Reproducibility of Results ROC Curve Lymph Node Excision Sensitivity and Specificity Tumor Burden Actuarial Analysis Treatment Failure Gene Expression Profiling Regression Analysis Registries Gastrectomy Reverse Transcriptase Polymerase Chain Reaction Multicenter Studies as Topic Probability Clinical Trials as Topic Incidence Life Tables Tomography, X-Ray Computed Salvage Therapy Patient Selection Hepatectomy Radiotherapy In Situ Hybridization, Fluorescence Odds Ratio Transplantation, Autologous Case-Control Studies Statistics, Nonparametric Karyotyping Hospital Mortality Biopsy Radiotherapy Dosage Cytogenetic Analysis Hematopoietic Stem Cell Transplantation Glasgow Outcome Scale Neoadjuvant Therapy Preoperative Care Leukocyte Count Cause of Death Pneumonectomy Disability Evaluation Research Design Nomograms Metastasectomy Clinical Trials, Phase III as Topic Magnetic Resonance Imaging Models, Statistical Epidemiologic Methods Oligonucleotide Array Sequence Analysis Esophagectomy Biopsy, Needle Prostatectomy Postoperative Period Polymerase Chain Reaction Longitudinal Studies Positron-Emission Tomography Neurosurgical Procedures Length of Stay Mastectomy Statistics as Topic Hospitalization Preoperative Period Reoperation Paraffin Embedding Clinical Trials, Phase II as Topic Chemoradiotherapy Confidence Intervals Glasgow Coma Scale

Phenomena and Processes18

Time Factors Pregnancy Outcome Gene Expression Regulation, Neoplastic Chi-Square Distribution Ploidies Sensitivity and Specificity Probability Pregnancy Chromosome Aberrations Odds Ratio Recovery of Function Mutation Leukocyte Count Nomograms Gene Amplification DNA Methylation Genes, p53 Drug Resistance, Neoplasm

Disciplines and Occupations4

Outcome Assessment (Health Care)Immunohistochemistry Research Design Statistics as Topic

Anthropology, Education, Sociology and Social Phenomena2

Survival Quality of Life

Humanities1

Quality of Life

Information Science8

Survival Rate Registries Incidence Life Tables Hospital Mortality Glasgow Outcome Scale Cause of Death Glasgow Coma Scale

Named Groups1

Infant, Newborn

Health Care57

Treatment Outcome Survival Analysis Survival Rate Retrospective Studies Multivariate Analysis Follow-Up Studies Disease-Free Survival Kaplan-Meier Estimate Proportional Hazards Models Predictive Value of Tests Outcome Assessment (Health Care)Prospective Studies Risk Factors Cohort Studies Age Factors Risk Assessment Severity of Illness Index Analysis of Variance Chi-Square Distribution Karnofsky Performance Status Randomized Controlled Trials as Topic Outcome and Process Assessment (Health Care)Logistic Models Reproducibility of Results ROC Curve Sensitivity and Specificity Actuarial Analysis Treatment Failure Sex Factors Regression Analysis Registries Multicenter Studies as Topic Probability Clinical Trials as Topic Incidence Life Tables Patient Selection Odds Ratio Case-Control Studies Statistics, Nonparametric Hospital Mortality Glasgow Outcome Scale Preoperative Care Cause of Death Nomograms Clinical Trials, Phase III as Topic Models, Statistical Epidemiologic Methods Postoperative Period Longitudinal Studies Length of Stay Statistics as Topic Hospitalization Preoperative Period Clinical Trials, Phase II as Topic Confidence Intervals Glasgow Coma Scale

Geographicals4

United States Japan France Italy

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Prognosis Treatment Outcome Survival Analysis Survival Rate Retrospective Studies Neoplasm Staging Multivariate Analysis Tumor Markers, Biological Follow-Up Studies Disease-Free Survival Kaplan-Meier Estimate Proportional Hazards Models Predictive Value of Tests Lymphatic Metastasis Neoplasm Recurrence, Local Outcome Assessment (Health Care)Prospective Studies Time Factors Immunohistochemistry Risk Factors Breast Neoplasms Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Cohort Studies Disease Progression Neoplasm Invasiveness Lung Neoplasms Adenocarcinoma Pregnancy Outcome Age Factors Recurrence Neoplasm Metastasis Risk Assessment Chemotherapy, Adjuvant Ki-67 Antigen Carcinoma, Squamous Cell Tissue Array Analysis Vincristine Severity of Illness Index Stomach Neoplasms Liver Neoplasms Carcinoma Neoplasm Grading Remission Induction Gene Expression Regulation, Neoplastic Analysis of Variance Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Lymph Nodes Chi-Square Distribution Mitotic Index Brain Neoplasms Karnofsky Performance Status Cyclophosphamide Receptors, Estrogen Radiotherapy, Adjuvant Prednisone Biological Markers Receptor, erbB-2 Doxorubicin Melanoma Antineoplastic Agents Ovarian Neoplasms Receptors, Progesterone Neoplasm Proteins Kidney Neoplasms Ploidies Acute Disease Hodgkin Disease Immunoenzyme Techniques Survival Sarcoma Esophageal Neoplasms Randomized Controlled Trials as Topic Outcome and Process Assessment (Health Care)Skin Neoplasms Carcinoma, Renal Cell Logistic Models Carcinoma, Ductal, Breast Bone Neoplasms Carcinoma, Hepatocellular Reproducibility of Results ROC Curve Lymph Node Excision Infant, Newborn Sensitivity and Specificity Neoplasm, Residual Tumor Suppressor Protein p53 Tumor Burden L-Lactate Dehydrogenase Lymphoma, Large B-Cell, Diffuse Actuarial Analysis Treatment Failure Sex Factors Leukemia, Myeloid, Acute Gene Expression Profiling Regression Analysis Registries Gastrectomy Lymphoma, Non-Hodgkin

No FAQ available that match "prognostic factors for outcomes"